Inactive Instrument

Other languages ATHENEXPAR

Equities

Athenex, Inc. Went Out of Business	23-09-22
First Motion for Exclusivity Period Extension Approved For Athenex, Inc.	23-09-18
First Motion for Exclusivity Period Extension Filed by Athenex, Inc.	23-09-08
Athenex, Inc. Announces the Separation of Joe Annoni as Assistant Chief Restructuring Officer	23-08-17
Illumina cuts annual profit forecast as biotech funding woes linger	23-08-09
Illumina cuts annual profit forecast	23-08-09
Modified Disclosure Statement Approved on Interim Basis for Athenex, Inc.	23-08-01
Athenex Plans to Sell Assets	23-05-15
Sector Update: Health Care Stocks Mostly Lower Late Monday	23-05-15
Sector Update: Health Care	23-05-15
Top Midday Decliners	23-05-15
Sector Update: Health Care Stocks Edge Higher Premarket Monday	23-05-15
Optimism Over Potential Debt Limit Increase Lifts Exchange-Traded Funds, Equity Futures Pre-Bell	23-05-15
Athenex Voluntarily Files for Chapter 11 Proceedings; Reaches Agreement to Pursue Expedited Sales Process of Certain Assets	23-05-15
Motion for Joint Administration Approved for Athenex, Inc.	23-05-14
Motion for Joint Administration Filed by Athenex, Inc.	23-05-14
Athenex, Inc. Filed for Bankruptcy	23-05-14
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with A PD-1 and Carboplatin from I-Spy2 Trial At Asco	23-05-01
Athenex, Inc Appoints Nick Campbell as Chief Restructuring Officer	23-04-25
Athenex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-20

No results for this search